RESIDENCE STRUCTURES AND RELATED METHODS
    3.
    发明公开
    RESIDENCE STRUCTURES AND RELATED METHODS 审中-公开
    WOHNUNGSSTRUKTUREN UNDZUGEHÖRIGEVERFAHREN

    公开(公告)号:EP3155024A1

    公开(公告)日:2017-04-19

    申请号:EP15806017.8

    申请日:2015-06-11

    IPC分类号: C08F8/00 C08G63/682

    摘要: Described are gastric residence structures that include an active substance. The gastric residence structures may include one or more arms that include a loadable polymeric component, an elastic polymeric component, and a separate linker component. The linker may connect the one or more arms with the elastic polymeric component. The gastric residence structures may be configured to be folded and physically constrained during administration and may be configured to assume an open retention shape upon removal of a constraint. The change between the folded shape and the open retention shape may be mediated by the elastic polymeric component that undergoes elastic deformation when the residence structure is in the folded shape and recoils when the gastric residence structure assumes the open retention shape.

    摘要翻译: 通常提供住宅结构,系统和相关方法。 某些实施方案包括将住院结构施用(例如,口服)给对象(例如,患者),使得住宿结构保持在受试者内部某一时间(例如,至少约24小时) 在被释放之前。 在一些情况下,住院结构可以是胃停留结构。 在一些实施方案中,本文所述的结构和系统包括一种或多种配置用于在酸性环境中高水平的活性物质(例如治疗剂)负载,高活性物质和/或结构稳定性,在内部的机械柔性和强度 孔(例如,胃腔),容易通过胃肠道直到输送到期望的内部孔口(例如胃腔),和/或在生理环境(例如,肠环境)中快速溶解/降解)和/或 对化学刺激剂的反应(例如,摄入引起快速溶解/降解的溶液)。 在某些实施方案中,该结构具有模块化设计,将配置用于控制释放治疗剂,诊断和/或增强剂的材料与胃停留所必需的结构材料组合,但被配置用于控制和/或可调节的降解/溶解以确定 保留形状完整性丧失并且结构从胃腔排出的时间。 例如,在某些实施方案中,宿主结构包括第一弹性组分,被配置成释放活性物质(例如治疗剂)的第二组分和任选的连接体。 在一些这样的实施方案中,接头可以被配置为降解,使得停留结构在预定量的时间之后分裂并且从受试者内部的位置释放。

    TEMPERATURE-CONTROLLED MEDICINAL STORAGE DEVICES
    5.
    发明公开
    TEMPERATURE-CONTROLLED MEDICINAL STORAGE DEVICES 审中-公开
    温度控制的药物储存装置

    公开(公告)号:EP3177257A1

    公开(公告)日:2017-06-14

    申请号:EP15830436.0

    申请日:2015-08-05

    申请人: Tokitae LLC

    IPC分类号: A61J1/14 A61J1/00

    摘要: In some embodiments, a medicinal storage container includes: a desiccant unit including external walls forming a gas-impermeable barrier around an interior desiccant region and including an aperture; a heating element; a controller operably attached to the heating element; a cooling unit; a compressor system including at least one evaporator coil unit, the compressor operably connected to the controller; a vapor conduit, the vapor conduit attached to a the desiccant unit at a first end, the vapor conduit attached to the evaporative cooling unit at a second end, the vapor conduit forming an internal, gas-impermeable passageway between the desiccant unit and the cooling unit; a vapor control unit attached to the vapor conduit and operably attached to the controller; and a medicinal storage unit including external walls encircling a medicinal storage region including a temperature sensor operably connected to the controller.

    摘要翻译: 在一些实施例中,药物储存容器包括:干燥剂单元,其包括形成围绕内部干燥剂区域并包括孔的不透气阻挡层的外壁; 加热元件; 可操作地连接到加热元件的控制器; 一个冷却单元; 压缩机系统,其包括至少一个蒸发器盘管单元,所述压缩器可操作地连接到所述控制器; 蒸气导管,所述蒸气导管在第一端处连接至所述干燥剂单元,所述蒸气导管在第二端处连接至所述蒸发冷却单元,所述蒸气导管在所述干燥剂单元与所述冷却单元之间形成不透气的内部通路 单元; 蒸气控制单元,所述蒸气控制单元附接到所述蒸气导管并可操作地附接到所述控制器; 以及药物储存单元,其包括环绕药物储存区域的外壁,所述药物储存区域包括可操作地连接到所述控制器的温度传感器。